Aanjaneya Lifecare Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 2,500,000 (50%) | — | ₹6,000 Cr |
| NII (HNI) | — | 750,000 (15%) | — | ₹1,800 Cr |
| Retail | — | 1,750,000 (35%) | — | ₹4,200 Cr |
| Σ Total | — | 5,000,000 (100%) | — | ₹120,000 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 25 | ₹6,000 |
| Retail (Max) | 13 | 325 | ₹78,000 |
| S-HNI (Min) | 14 | 350 | ₹84,000 |
| B-HNI (Min) | 67 | 1,675 | ₹402,000 |
Financial Statements Amount in Lakhs
| Metric | 31-Jan-11 | 31-Mar-10 | 31-Mar-09 |
|---|---|---|---|
| Revenue | 29,258 | 16,936 | 9,116 |
| Profit After Tax | 3,105 | 1,508 | 511 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Setting up of Anti Cancer API Facility at Mahad, Maharashtra – 26.55
- 2 Setting up of cGMP Block for APIs at Mahad, Maharashtra – 14.80
- 3 Setting up of Intermediate API Block at Mahad, Maharashtra – 8.67
- 4 Expansion of our existing Research and Development centre at Mahad and Pune, Maharashtra – 19.08
- 5 Setting up of a Quality Control and Quality Assurance Block at Mahad, Maharashtra – 14.20
- 6 Setting up of Product Development Laboratory at Mahad, Maharashtra – 1.61
- 7 Setting up of Stores Building at Mahad, Maharashtra – 7.06
- 8 Meeting the Expenses for Branding and Registration of our Products in the International Markets – 10.00
- 9 General Corporate Purposes – 6.61
Company Overview
Incorporated in 2006, Aanjaneya Lifecare Ltd a leading research based integrated pharmaceutical company with established research, manufacturing & marketing capabilities. Company’s product portfolio includes Bulk Drugs, Finished Dosage Forms, Herbal Medicines, Inhalers, Lozenges and Animal Health.
Aanjaneya has a manufacturing facility in Mahad near Mumbai. This facility provides multi-therapeutic product offerings comprising high-end Alkaloids, Quinine Salts, and Veterinary APIs & Cytotoxic API's.
Company also has a Finished Dosages Facility at Perungut Pune. This facility is for manufacturing various types of dosage forms such as Liquid Syrups, oral tablets, lozenges and Gels in several product categories complying with international standards.
Aanjaneya‘s manufacturing facilities are ISO 9001-2000 and WHO GMP certified. As on March 31st 2010 Aanjaneya had 222 employees.